• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan+
  • Wellness
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan+
  • Wellness
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Hematology

Inflammatory bowel disease may increase risk of venous thromboembolism in children

bySimon PanandAlex Chan
March 12, 2025
in Hematology, Pediatrics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Children living with inflammatory bowel disease (IBD) are at greater risk of venous thromboembolism (VTE) compared to children without VTE, with the highest risk occurring around time of diagnosis. 

Evidence Rating Level: 2 (Good)

Evidence from recent studies suggest that children living with IBD are at greater risk of VTE compared to children without IBD. However, due to the rarity of VTE in IBD patients in spite of this increased risk, studies have been limited to a lower number of events, making it difficult to characterize VTE risk in children beyond incidence rates. This study therefore sought to characterize children with IBD who develop VTE and to calculate absolute and relative risks compared to the general population. Patients under the age of 18 with IBD between 2001 and 2019 were identified via HES, a nationwide administrative database of all hospitals in England. A comparator cohort was constructed using data from children without IBD from the Office for National Statistics as well as HES data. The absolute risk of VTE in the general pediatric population was 0.18 (95% confidence interval [CI], 0.18-0.19) per 10,000 patient-years, while it was 9.42 (95% CI, 7.4-11.4) per 10 000 patient-years for pediatric patients living with IBD. Among children living with IBD, there was an overall relative risk increase of 51.8 (95% CI, 41.8-64.3) compared to children without IBD. When analyzing based on demographic factors, children with ulcerative colitis were at a higher risk for VTE compared to children with Crohn’s disease (incidence rate 12.4 vs 5.6 per 10 000 patient-years). Among children with IBD and VTE, 65 (76.5%) developed a VTE either within the first year following IBD diagnosis or 6 months prior to IBD diagnosis. Overall, this study found that children living with IBD are at increased risks of developing a VTE, with the greatest risk occurring around the time of diagnosis.

Click to read the study in the study in Inflammatory Bowel Disease 

Image: PD

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

RELATED REPORTS

Worsening kidney function observed following SARS-CoV-2 infection in children

2MM: AI Roundup – FDA’s AI Push, Trial Speedups with Real-World Data, Smart Surgical Monitors, and Regulatory Overhaul Begins [May 23rd, 2025]

Twice-yearly lenacapavir prevents HIV more effectively than daily F/TDF

Previous Post

Poor control over clinical work associated with burnout among physicians

Next Post

#VisualAbstract: Tenecteplase is Non-Inferior to Alteplase for Acute Ischemic Stroke within 4.5 Hours of Onset

RelatedReports

Being overweight and obese associated with increased incidence of chronic kidney disease
Chronic Disease

Worsening kidney function observed following SARS-CoV-2 infection in children

May 23, 2025
2MM: AI Roundup- AI Cancer Test, Smarter Hospitals, Faster Drug Discovery, and Mental Health Tech [May 2nd, 2025]
AI Roundup

2MM: AI Roundup – FDA’s AI Push, Trial Speedups with Real-World Data, Smart Surgical Monitors, and Regulatory Overhaul Begins [May 23rd, 2025]

May 23, 2025
Pre-exposure prophylaxis (PrEP) effective in preventing HIV infection in high-risk gay men
Chronic Disease

Twice-yearly lenacapavir prevents HIV more effectively than daily F/TDF

May 22, 2025
#VisualAbstract: Efruxifermin Did Not Reduce Liver Fibrosis in Compensated Liver Cirrhosis Caused by MASH
StudyGraphics

#VisualAbstract: Efruxifermin Did Not Reduce Liver Fibrosis in Compensated Liver Cirrhosis Caused by MASH

May 22, 2025
Next Post
#VisualAbstract: Tenecteplase is Non-Inferior to Alteplase for Acute Ischemic Stroke within 4.5 Hours of Onset

#VisualAbstract: Tenecteplase is Non-Inferior to Alteplase for Acute Ischemic Stroke within 4.5 Hours of Onset

Study lends support for interferon-free treatment of hepatitis C

Machine learning model demonstrates superior screening efficiency for Hepatitis C virus carriers

Elagolix with add-back hormone therapy effective in reducing fibroid-associated menstrual bleeding

Endometriosis and uterine fibroids associated with a greater risk of mortality due to gynecologic cancers

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Worsening kidney function observed following SARS-CoV-2 infection in children
  • 2MM: AI Roundup – FDA’s AI Push, Trial Speedups with Real-World Data, Smart Surgical Monitors, and Regulatory Overhaul Begins [May 23rd, 2025]
  • Twice-yearly lenacapavir prevents HIV more effectively than daily F/TDF
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.